VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics Ltd. has successfully completed the first portion of its non-brokered private placement, raising $300,000 through unsecured convertible debentures, which insiders also invested in. These debentures come with a 10% annual interest rate, convertible into common shares at predetermined prices, and include automatic conversion features under certain conditions along with warrant incentives.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
